Puniska

Ahmedabad, India Founded: 2017 • Age: 9 yrs Acquired By Amneal
Therapeutic products are developed and manufactured by Puniska.

About Puniska

Puniska is a Healthcare company based in Ahmedabad (India) founded in 2017 by Karan Patel, Kalpesh Patel, and Shalin Patel, and was acquired by Amneal in November 2021. Therapeutic products are developed and manufactured by Puniska. The company has 506 employees. Its Indian entity Puniska Injectables Private Limited reported revenue of β‚Ή170 Cr. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.

Company details

Puniska was founded in 2017 and is based in Ahmedabad, India. Operations center on the development and manufacturing of therapeutic products within the healthcare sector. Co-founders Karan Patel, Kalpesh Patel, and Shalin Patel oversee key activities. The companys domain, puniska.com, supports its online presence, with focus placed on product innovation and production processes tailored to therapeutic needs.

  • Headquarters Ahmedabad, India
  • Employees 506
  • Founders Karan Patel, Kalpesh Patel, Shalin Patel
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website puniska.com
  • Social LinkedIn
  • Acquired by Amneal (Nov 2021)
  • Legal Name Puniska Injectables Private Limited
  • Date of Incorporation 14 May, 2022
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹170 Cr

    FY 2025 · +21% YoY

  • Net Loss
    -₹5.60 Cr

    FY 2025 · -3% margin

  • EBITDA
    ₹5.78 Cr

    FY 2025 · 3% margin

  • Investors
  • Employee Count
    506
  • Acquired by
    Amneal

    (Nov 2021)

Investors in Puniska

Puniska has secured backing from 1 investor. Prominent investors backing the company include Amneal.

All
InvestorDescriptionFounded YearDomainLocation
Manufacturer of generics formulations
2002amneal.comBridgewater, United States
Premium access

Investor details for Puniska

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Puniska Injectables Private Limited (Puniska)

Puniska Injectables Private Limited is the primary company behind Puniska. The boards of the 3 registered companies of Puniska currently have 7 directors; the longest-serving is Kalpesh Ambubhai Patel, appointed in 2018. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kalpesh Ambubhai Patel
DIN 00322811
Designated Partner05 Mar 20188 yrs 8 moPuniska Properties Llp, Puniska Injectables Private Limited
Punitaben Kalpeshbhai Patel
DIN 07667369
Designated Partner05 Mar 20188 yrs 8 moPuniska Properties Llp, Puniska Injectables Private Limited
Rajeev Midha
DIN 08343797
Director02 Nov 20215 yrsPuniska Healthcare Private Limited
Sanjay Kumar Jain
DIN 07951871
Director02 Nov 20215 yrsPuniska Healthcare Private Limited
Maheshkumar Bhagwansingh Yadav
DIN 07224446
Director15 Jun 20224 yrs 5 moPuniska Injectables Private Limited
Neha Verma
DIN 07929641
Company Secretary15 Jun 20224 yrs 5 moPuniska Injectables Private Limited
Manojkumar Shah Jashwantlal
DIN 05266030
Director15 Jun 20224 yrs 5 moPuniska Injectables Private Limited

People of Puniska

3 people are tracked at Puniska (3 in leadership); the tracked headcount is 506.

NameRoleGroup
Karan Patel
Co-FounderLeadership
Co-FounderLeadership
Shalin Patel
Co-FounderLeadership
Premium access

Complete people profiles for Puniska

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Puniska

Figures of Puniska Injectables Private Limited, the primary company behind Puniska, for FY 2025. Revenue was ₹170 Cr (+21% year on year). Net loss was -₹5.60 Cr (-3% margin). EBITDA was ₹5.78 Cr (3% margin).

  • ₹170 CrRevenue · FY 2025 · +21% YoY
  • -₹5.60 CrNet loss · -3% margin
  • ₹5.78 CrEBITDA · 3% margin
  • ₹10 LakhPaid-up capital
  • 281Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Puniska Injectables Private Limited are on its company page.

Premium access

Detailed financial statements for Puniska

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Puniska

2 dated milestones of Puniska across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Puniska is founded.
  2. Exit Acquired by Amneal.

Competitors of Puniska

Puniska has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of Puniska

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Puniska

The website of Puniska (puniska.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▼ 77.5% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Puniska (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Puniska

Puniska was founded in 2017.

Puniska is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Puniska has 506 employees.

The primary company behind Puniska, Puniska Injectables Private Limited, reported revenue of β‚Ή170 Cr for FY 2025, up 21% year on year.

Puniska was founded in 2017 and is based in Ahmedabad, India. Operations center on the development and manufacturing of therapeutic products within the healthcare sector. Co-founders Karan Patel, Kalpesh Patel, and Shalin Patel oversee key activities. The companys domain, puniska.com, supports its online presence, with focus placed on product innovation and production processes tailored to therapeutic needs.

Puniska has 1 investor. Key investors include Amneal.

Puniska is associated with 3 legal entities: Puniska Injectables Private Limited, Puniska Properties Llp, Puniska Healthcare Private Limited.

Yes. Puniska was acquired by Amneal in November 2021.

The legal entities of Puniska currently have 7 directors, including Kalpesh Ambubhai Patel, Punitaben Kalpeshbhai Patel, Maheshkumar Bhagwansingh Yadav and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available